About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00584961

BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder

To assess the prevalence of Metabolic Syndrome in Spanish population with Bipolar I or II Disorder. To analyse the clinical progress disease in patients with Bipolar I or II Disorder for 12 months us...

Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Consecutive patient sampling. In any investigational site, five consecutive patients with diagnosis of Bipolar Disorder will be enrolled in the study

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with diagnosis of Bipolar Disorder (DSM-IV TR)
•Patients or their legal representatives have provided informed consent

Exclusion Criteria

•Patients are unable to complete or to understand health questionnaires in Spanish language
•Patients enrolled in clinical trials or other studies

Related studies

Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity

NCT07589647 · Bipolar Disorder (BD)

RECRUITINGPhase 2

Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder

NCT06226025 · Bipolar Disorder, Delayed Sleep-Wake Phase Disorder

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

NCT07140913 · Mania, Bipolar Disorder

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

NCT06920940 · Bipolar Disorder (BD), Bipolar Disorder NOS, and more

RECRUITINGPhase 3

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

NCT07172516 · Bipolar Disorder, Bipolar Depression, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 21, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment553

Start dateMay 2007

Last updatedFeb 21, 2021

Condition

Bipolar Disorder

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 21, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions